(Q28533828)
Statements
Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial (English)
0 references
2013
0 references
8
0 references
9
0 references
e74314
0 references
26 September 2013
1 reference
1 reference
1 reference
1 reference